PAVmed ^{Priced, Nasdaq: PAVM}

We are a medical device company organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs and possess attractive market opportunities. Our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency. We intend to continuously explore promising ideas and opportunities that fulfill our project selection criteria without limiting ourselves to any target specialty or condition. Our current pipeline includes the following five lead projects, all of which are the subject of patent applications filed. One of these projects, NextFlo, also has an issued patent. These include PortIO, a long-term implantable vascular access device; Caldus, a disposable tissue ablation device; CarpX, a percutaneous device to treat carpal tunnel syndrome; NextCath, a self-anchoring short-term catheter; and NextFlo, a highly-accurate disposable infusion pump.